Literature DB >> 15850756

Chemokine receptor 5 and its ligands in the immune response to murine tuberculosis.

A P Badewa1, L J Quinton, J E Shellito, C M Mason.   

Abstract

SETTING: The ability of chemokines such as macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and regulated-upon-activation, normal T cell expressed and secreted (RANTES), to attract and activate T cells and monocytes, the building blocks of the granuloma, suggests that these chemokines may have a role in modulating immune responses to Mycobacterium tuberculosis infection.
OBJECTIVE: We hypothesized that the chemokine receptor 5 (CCR5) ligands, MIP-1alpha, MIP-1beta and RANTES, are virulence correlates in M. tuberculosis infection and are indispensable to granuloma formation.
DESIGN: The ability of virulent (H37Rv) and avirulent (H37Ra) strains of M. tuberculosis to induce chemokine production in vivo and in vitro was determined at protein and mRNA levels. We also compared bacterial burden, and granuloma numbers and size in H37Rv-infected CCR5-/- or wild-type C57BL/6 mice.
RESULTS: In vivo, lung mRNA and protein measurements of MIP-1alpha, MIP-1beta and RANTES indicate significantly higher (p<0.05) values (days 14-28) in the H37Rv-infected than the H37Ra-infected mice. This is consistent with a higher infection burden of the virulent strain. However, in vitro alveolar macrophage stimulation by H37Rv or H37Ra yielded no significant differences in production of the three chemokines at all time points. Histological analysis of granulomas did not show any significant differences in granuloma numbers, size and M. tuberculosis growth in CCR5-/- compared to wild-type mice.
CONCLUSIONS: The production of the CCR5 ligands, MIP-1alpha, MIP-1beta, and RANTES, does not clearly correlate with virulence of M. tuberculosis. These ligands and their receptors may not be indispensable to the development of granulomas in murine tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15850756     DOI: 10.1016/j.tube.2004.10.003

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  9 in total

Review 1.  Chemokines shape the immune responses to tuberculosis.

Authors:  Samantha R Slight; Shabaana A Khader
Journal:  Cytokine Growth Factor Rev       Date:  2012-11-16       Impact factor: 7.638

2.  CCL5 participates in early protection against Mycobacterium tuberculosis.

Authors:  Bridget Vesosky; Erin K Rottinghaus; Paul Stromberg; Joanne Turner; Gillian Beamer
Journal:  J Leukoc Biol       Date:  2010-04-06       Impact factor: 4.962

Review 3.  The role of dendritic cells in mycobacterium-induced granulomas.

Authors:  Heidi A Schreiber; Matyas Sandor
Journal:  Immunol Lett       Date:  2010-01-04       Impact factor: 3.685

4.  The adaptor molecule CARD9 is essential for tuberculosis control.

Authors:  Anca Dorhoi; Christiane Desel; Vladimir Yeremeev; Lydia Pradl; Volker Brinkmann; Hans-Joachim Mollenkopf; Karin Hanke; Olaf Gross; Jürgen Ruland; Stefan H E Kaufmann
Journal:  J Exp Med       Date:  2010-03-29       Impact factor: 14.307

5.  Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4.

Authors:  Simone A Joosten; Krista E van Meijgaarden; Nigel D L Savage; Tjitske de Boer; Frédéric Triebel; Annemieke van der Wal; Emile de Heer; Michèl R Klein; Annemieke Geluk; Tom H M Ottenhoff
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-02       Impact factor: 11.205

Review 6.  Cellular and humoral mechanisms involved in the control of tuberculosis.

Authors:  Joaquin Zuñiga; Diana Torres-García; Teresa Santos-Mendoza; Tatiana S Rodriguez-Reyna; Julio Granados; Edmond J Yunis
Journal:  Clin Dev Immunol       Date:  2012-05-17

7.  Untargeted metabolomics analysis reveals Mycobacterium tuberculosis strain H37Rv specifically induces tryptophan metabolism in human macrophages.

Authors:  Guohui Xiao; Su Zhang; Like Zhang; Shuyan Liu; Guobao Li; Min Ou; Xuan Zeng; Zhaoqin Wang; Guoliang Zhang; Shuihua Lu
Journal:  BMC Microbiol       Date:  2022-10-17       Impact factor: 4.465

Review 8.  Host innate immune response to Mycobacterium tuberculosis.

Authors:  Kamlesh Bhatt; Padmini Salgame
Journal:  J Clin Immunol       Date:  2007-03-16       Impact factor: 8.542

9.  Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection.

Authors:  Diana Di Liberto; Massimo Locati; Nadia Caccamo; Annunciata Vecchi; Serena Meraviglia; Alfredo Salerno; Guido Sireci; Manuela Nebuloni; Neus Caceres; Pere-Joan Cardona; Francesco Dieli; Alberto Mantovani
Journal:  J Exp Med       Date:  2008-08-11       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.